This article has been updated with comments from Caliper's conference call.

NEW YORK (GenomeWeb News) – Caliper Life Sciences today reported a decline of 9 percent in its fourth-quarter revenues — in line with its guidance — while taking a $45.3 million charge for goodwill impairment and other restructuring charges.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.